Back
Fate Therapeutics, Inc. Stock Price Chart
Know when to buy, sell, or hold. Rate Any Stock In Seconds
Get Your Free Stock Analysis Now
Sell
48
FATE
Fate Therapeutics, Inc.
Last Price:
$1.20
Seasonality Move:
8.67%
7 Day Trial
ALL ACCESS PASS
$
7
Color-coded buy, sell, hold signals make stock decisions simple.
Get Your Free Stock Analysis Now-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and FATE is experiencing slight buying pressure.
Fate Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.21 | Sell |
| 20-day SMA: | 1.11 | Buy |
| 50-day SMA: | 1.07 | Buy |
| 200-day SMA: | 1.16 | Buy |
| 8-day EMA: | 0.79 | Buy |
| 20-day EMA: | 0.41 | Buy |
| 50-day EMA: | 0.18 | Buy |
| 200-day EMA: | 0.05 | Buy |
Fate Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 56.31 | Buy |
| Chaikin Money Flow: | -1620174 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Fate Therapeutics, Inc. Technical Analysis
| Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | Jan 23 | Jan 26 | Jan 27 | Jan 28 | Jan 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 15 | 16 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Fate Therapeutics, Inc. Stock
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.21 while FATE 8-day simple moving average is 1.21, which is a Sell signal.
-
The stock price of FATE is 1.21 while Fate Therapeutics, Inc. 20-day SMA is 1.11, which makes it a Buy.
-
Fate Therapeutics, Inc. 50-day simple moving average is 1.07 while FATE share price is 1.21, making it a Buy technically.
-
FATE stock price is 1.21 and Fate Therapeutics, Inc. 200-day simple moving average is 1.16, creating a Buy signal.
FATE Technical Analysis vs Fundamental Analysis
Sell
48
Fate Therapeutics, Inc. (FATE)
is a Sell
Is Fate Therapeutics, Inc. a Buy or a Sell?
-
Fate Therapeutics, Inc. stock is rated a SellThe current Fate Therapeutics, Inc. [FATE] share price is $1.21. The Score for FATE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
Fate Therapeutics, Inc. Stock Info
Market Cap:
137.8M
Price in USD:
1.21
Share Volume:
2.3M
Fate Therapeutics, Inc. 52-Week Range
52-Week High:
1.94
52-Week Low:
0.66
Sell
48
Fate Therapeutics, Inc. (FATE)
is a Sell
Fate Therapeutics, Inc. Share Price Forecast
-
What is the Fate Therapeutics, Inc. stock price today?The Fate Therapeutics, Inc. stock price is 1.21 USD today.
-
Will FATE stock go up or go down?Fate Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Fate Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Fate Therapeutics, Inc. is overvalued.
Is Fate Therapeutics, Inc. Stock a Buy?
-
Fate Therapeutics, Inc. share price is 1.21 while FATE 8-day exponential moving average is 0.79, which is a Buy signal.
-
The stock price of FATE is 1.21 while Fate Therapeutics, Inc. 20-day EMA is 0.41, which makes it a Buy.
-
Fate Therapeutics, Inc. 50-day exponential moving average is 0.18 while FATE share price is 1.21, making it a Buy technically.
-
FATE stock price is 1.21 and Fate Therapeutics, Inc. 200-day simple moving average is 0.05, creating a Buy signal.
Fundamental Analysis of Fate Therapeutics, Inc.
Is Fate Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.14 per share.
Technical Analysis of Fate Therapeutics, Inc.
Should I short Fate Therapeutics, Inc. stock?
-
FATE Moving Average Covergence Divergence (MACD) indicator is 0.28, suggesting Fate Therapeutics, Inc. is a Buy
-
Fate Therapeutics, Inc. Relative Strength Index (RSI) is 56.31, which suggest Fate Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Fate Therapeutics, Inc. is ( - ), which suggest Fate Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Fate Therapeutics, Inc. is ( - ), which suggest Fate Therapeutics, Inc. is a Buy
* Fate Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.